CIK 0001275187 · Accelerated filer
ANGIODYNAMICS INC
Sign in to watch- Ticker
- ANGO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113146460
- Phone
- 5187981215
- Business address
- 14 PLAZA DRIVE, LATHAM, NY, 12110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $310,688
- in 1 filing
Net −$310,688. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-18 | Helsel Dave SVP Global Operations and R&D | Shares withheld for taxes | −736 | $15.57 | $11K | 16,422 |
| 2019-10-25 | Clemmer James C President and CEO | Purchase | +15,000 | $14.19 | $213K | 260,418 |
| 2019-10-16 | Trowbridge Stephen A SVP and General Counsel | Grant or award · Performance Right | +8,357 | 8,357 | ||
| 2019-10-16 | Greiner Michael EVP and CFO | Grant or award · Performance Right | +15,320 | 15,320 | ||
| 2019-10-16 | Clemmer James C President and CEO | Grant or award · Performance Right | +50,139 | 50,139 | ||
| 2019-10-16 | Helsel Dave SVP Global Operations and R&D | Grant or award · Performance Right | +6,945 | 6,945 | ||
| 2019-10-16 | Campbell Chad Thomas SVP/GM, Vascular Access | Grant or award · Performance Right | +6,195 | 6,195 | ||
| 2019-10-16 | Boucher Brent J. SVP and GM of Oncology | Grant or award · Performance Right | +6,452 | 6,452 | ||
| 2019-08-18 | Greiner Michael EVP and CFO | Shares withheld for taxes | −826 | $19.10 | $16K | 33,438 |
| 2019-08-06 | JOHNSON WESLEY Director | Option exercise | +6,650 | $10.68 | $71K | 72,669 |
| 2019-08-06 | JOHNSON WESLEY Director | Shares withheld for taxes | −3,581 | $19.83 | $71K | 69,088 |
| 2019-08-06 | JOHNSON WESLEY Director | Option exercise · Non-Qualified Stock Option (right to buy) | −6,650 | 0 | ||
| 2019-07-27 | Clemmer James C President and CEO | Shares withheld for taxes | −1,752 | $20.91 | $37K | 141,558 |
| 2019-07-27 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −252 | $20.91 | $5K | 18,928 |
| 2019-07-27 | Trowbridge Stephen A SVP and General Counsel | Shares withheld for taxes | −285 | $20.91 | $6K | 37,723 |
| 2019-07-26 | Clemmer James C President and CEO | Shares withheld for taxes | −1,826 | $20.89 | $38K | 143,310 |
| 2019-07-26 | Campbell Chad Thomas SVP/GM, Vascular Access | Shares withheld for taxes | −276 | $20.89 | $6K | 19,180 |
| 2019-07-26 | Simpson Robert Arthur SVP/GM, Global Vascular | Shares withheld for taxes | −309 | $20.89 | $6K | 15,441 |
| 2019-07-26 | Trowbridge Stephen A SVP and General Counsel | Shares withheld for taxes | −306 | $20.89 | $6K | 38,008 |
| 2019-07-26 | Greiner Michael EVP and CFO | Shares withheld for taxes | −511 | $20.89 | $11K | 27,304 |
Page 24 of 30 · 589 trades